Accordingly, we adjusted the multivariate analyses for AF IL-6 levels and found that elevated FCGBP levels and lower VEFGR-1 levels in AF were significantly associated with the risk of SPTD ≤ 14 days after sampling, independently of the AF IL-6 level (Table 3). This evidence concerns the gene IL6 and atrial fibrillation.